MedTrace Logo

The SurgiMend PRS Retrospective Study

NCT05182177 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2025-02-14

No results posted yet for this study

Summary

The SurgiMend® PRS Retrospective Study will evaluate the performance and safety of SurgiMend® PRS and SurgiMend® PRS Meshed when used for soft tissue reinforcement under the product's indications for use.

Conditions

  • Reconstructive Surgical Procedures

Interventions

DEVICE

SurgiMend PRS

SurgiMend® PRS and SurgiMend® PRS Meshed are intended for implantation to reinforce soft tissue where weakness exists and for surgical repair of damaged or ruptured soft tissue membranes. SurgiMend® PRS and SurgiMend® PRS Meshed are specifically indicated for plastic and reconstructive surgery, including breast reconstruction.

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Italy
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05182177 on ClinicalTrials.gov